Lamivudine and Tenofovir Disoproxil Fumarate
Lamivudine and Tenofovir Disoproxil Fumarate is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including CIMDUO. Available dosage form: tablet, film coated.
Drug details
- Generic Name
- Lamivudine and Tenofovir Disoproxil Fumarate
- Brand Names
- CIMDUO
- Application Number
- NDA022141
- Sponsor
- Viatris Specialty LLC
- NDC Codes
- 1
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE
Indications and Usage
1 INDICATIONS AND USAGE CIMDUO ® (lamivudine and tenofovir disoproxil fumarate) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients weighing at least 35 kg. CIMDUO is a two-drug combination of lamivudine (3TC) and tenofovir disoproxil fumarate (TDF), both nucleo(t)side reverse transcriptase inhibitors and is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients weighing at least 35 kg. ( 1 )